This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $7,699.09, is a delivery order for pharmaceutical products including Amlodipine-Valsartan-Hydrochlorothiazide 10-160-12.5 mg tablets. The contract has an ultimate completion date of January 2, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 4/1/25, 10:48 AM